Recon: Sanofi, GSK to supply 200M vaccine doses to COVAX scheme; US strikes deal for Lilly’s COVID antibody drug

• Pfizer CEO All but Rules Out Vaccine Before Election Day (NYTimes) (FT)
• US strikes deal with Lilly for potential COVID-19 antibody drug (Reuters) (Endpoints) (Press)
• Lawmakers release trove of Purdue documents detailing Sackler family’s involvement in opioid sales (STAT)
• I'm the FDA point person on COVID-19 vaccines. We'll make sure they're safe and effective. (USA Today)
• US pharmacies attract new flu shot customers as coronavirus surges (Reuters)
• The coronavirus vaccine race slams into reality (Politico)

• UK says COVID-19 vaccine roll out could start before Christmas (Reuters)
• Sanofi, GSK to supply vaccine doses to WHO-backed alliance (Reuters)
• Russia applies for WHO emergency use tag for its COVID-19 vaccine (Reuters)
• UK starts real-time review of Moderna's COVID-19 vaccine candidate (Reuters)
• Back to crisis mode, EU moves to avoid COVID shortages, ease trade (Reuters) (EC)
• Supply of potential COVID-19 vaccines to start in earnest in April: EU's von der Leyen (Reuters)
• UK vaccine chief targets spring rollout, but impact may be limited (Reuters)
• Molecular Partners jumps after Novartis deal for potential COVID-19 drugs (Reuters) (BioPharmaDive)

• Scientists Warn Americans Are Expecting Too Much From a Vaccine (KHN)
• Meet the youngest participants in Covid-19 vaccine trials: Teens and tweens (NBC)
• Italy okays trial of osteoporosis drug to treat COVID-19 (Reuters)
• Why You Shouldn’t Worry About Studies Showing Waning Coronavirus Antibodies (NYTimes)
• Some Covid Survivors Have Antibodies That Attack the Body, not Virus (NYTimes)
• How The U.S. Plans To Distribute Potential Coronavirus Vaccines (NPR)
• States will need billions to distribute the Covid vaccine as federal funding falls short (CNBC)
• 3M is making more N95 masks than ever as global Covid cases rise, CEO says (CNBC)

• Novartis reports Q3 results, raises FY guidance (Seeking Alpha)
• GSK Q3 top-line down 8%, Shingrix sales drop 30%, Eliipta sales +21% (Seeking Alpha)
• GSK culls top respiratory disease prospect, delivering another blow to IL-33 field (Fierce)
• PDUFA VII: US FDA Wants Dedicated RMAT Program Funding (Pink Sheet)
• ‘Dying waiting’: Advocates urge Vertex to widen global access to cystic fibrosis drugs (STAT)
• In a Battered New York Office Market, Life Science Is Flourishing (NYTimes)
• FDA Approves Lotion for Nonprescription Use to Treat Head Lice (FDA)
• Flagship brings 'intersystems biology' under one roof with Senda Biosciences (Fierce)
• Tom Abrams’ Steady Leadership Guided US FDA Through Dramatic Changes In Rx Promotion (Pink Sheet)
• Indian drugmaker failed to notify FDA multiple times about issues with its sterile injectables: letter (Fierce)
• Bristol Myers' Richard Hargreaves pays $70M to launch a neurodegeneration alliance with a star player in the machine learning world (Endpoints)
• Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem (Endpoints)
• Roche's major cancer research exec Rommel jumps ship to Bayer as Moeller exits (Fierce)
• Vacaville Unveils California Biomanufacturing Center (GEN)
• Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer (Endpoints)
• UK Confirms It Will Accept EU Marketing Authorizations For Two Years (Pink Sheet)
• EU Framework For Patient Preference Studies Under Review (Pink Sheet)
• A dark horse entrant into the spinal muscular atrophy field doubles its value on some PhII data (Endpoints)
• Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia (Press)
• The Drug Supply Chain Security Act Pilot Project Program and Enhanced Drug Distribution Security – Public Meeting (FDA)
• Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism (Endpoints)
• RemeGen readies $514M IPO as HKEX adds jewel to the crown (Endpoints)

• Experts Call For Unifying Measures For EU Political And Regulatory Oversight (MedtechInsight)
• IVDR Implementation Not Yet On Track: What The Diagnostics Sector Needs To Do (MedtechInsight)
• FDA clears Abiomed's Breethe lung life support system, enabling use in COVID-19 (Fierce)
• MDUFA V: FDA Looks For More User-Fee Investments; Industry Wants To Work With What’s There (MedtechInsight)
• FDA Bumps PMA Compliance Date For AED Accessories To February 2022 (MedtechInsight) (FDA)
• Singapore HSA will introduce UDI labeling requirements for medical devices (Emergo)
• LabCorp sees Q3 revenue rise 33%, but doesn't follow Quest in upping guidance (MedtechDive)

• Department of Justice Files Complaint Against California Company To Stop Distribution of Adulterated Animal Drugs (DoJ)
• Suboxone Manufacturer Indivior's Former Chief Executive Officer Sentenced to Jail Time in Connection with Drug Safety Claims (FDA)
• Judge Wants New Bellwether List In Cook Vein Filter MDL (Law360)